ascendis pharma glp-1 receptor agonist weight management diabetes treatments Understanding agonists and their impact on drug discovery GLP-1 receptor agonists are transforming
Description
The Journal of Pathology
2.3%) and there was no difference in the percentage of participants with acute pancreatitis or malignant neoplasms between the two groups [110]
doi: 10.1161/atv.0000615456.97862.30
doi: 10.3390/ijms242417147
This has prompted critical discussions about prioritising access between different patient subgroups
FIGURE 3 Taken together, these mechanistic data and large-scale epidemiological findings point to a possible protective effect of GLP-1RAs against selected OACs
